Funding for this research was provided by:
Received: 23 October 2018
Accepted: 11 June 2019
First Online: 24 June 2019
Ethics approval and consent to participate
: This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects/patients and each site specific protocol was also approved by the ethical review boards of the participating institutions. The overarching ELANS protocol was approved by the Western Institutional Review Board (#20140605) and is registered at Clinical Trials (#NCT02226627).Argentina: Comité de ética de la Asociación Médica Argentina; Brazil: Comité de ética do Instituto Pensi – Fundação José Luiz Setubal – Hospital Infantil Sabara; Chile: Comité de ético científico de la Facultad de Medicina de la Pontificia Universidad Católica de Chile; Colombia: Comité de Investigación y ética de la Faculdade de Ciencias de la Pontificia Universidad Javeriana; Costa Rica: Comité ético científico de la Vicerrectoría de Investigación de La Universidad de Costa Rica; Ecuador: Comité de Bioética Universidad de San Francisco de Quito; Peru: Comité Institucional de ética del Instituto de Investigación Nutricional; Venezuela: Comisión de Bioética de la Escuela de Antropología de la Universidad Central de Venezuela.An document provided a short description of the purpose of the survey, confidentiality practices, contact information, and a link to the survey. Participants were considered consented once they read the document and signed to the survey. Informed assent was obtained from every adolescents and all parents and/or legal guardians signed an informed consent. All participants signed a written informed consent/assent before commencement of the study. Participants’ confidentiality for the pooled data was maintained using numeric identification codes rather than names. All data transfer was done with a secure file sharing system.
: Not applicable.
: All authors declare that they have no competing interests.